329 related articles for article (PubMed ID: 15120617)
21. Tweak induces mammary epithelial branching morphogenesis.
Michaelson JS; Cho S; Browning B; Zheng TS; Lincecum JM; Wang MZ; Hsu YM; Burkly LC
Oncogene; 2005 Apr; 24(16):2613-24. PubMed ID: 15735761
[TBL] [Abstract][Full Text] [Related]
22. Calcium dependent and independent cytokine synthesis by air pollution particle-exposed human bronchial epithelial cells.
Sakamoto N; Hayashi S; Gosselink J; Ishii H; Ishimatsu Y; Mukae H; Hogg JC; van Eeden SF
Toxicol Appl Pharmacol; 2007 Dec; 225(2):134-41. PubMed ID: 17720209
[TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB in human endometriotic epithelial cells.
Grund EM; Kagan D; Tran CA; Zeitvogel A; Starzinski-Powitz A; Nataraja S; Palmer SS
Mol Pharmacol; 2008 May; 73(5):1394-404. PubMed ID: 18252806
[TBL] [Abstract][Full Text] [Related]
24. Expression of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor-inducible 14 protein (Fn14), in healthy tissues and in tissues affected by periodontitis.
Kataria NG; Bartold PM; Dharmapatni AA; Atkins GJ; Holding CA; Haynes DR
J Periodontal Res; 2010 Aug; 45(4):564-73. PubMed ID: 20546112
[TBL] [Abstract][Full Text] [Related]
25. TWEAK/Fn14 promotes apoptosis of human endometrial cancer cells via caspase pathway.
Wang D; Fung JN; Tuo Y; Hu L; Chen C
Cancer Lett; 2010 Aug; 294(1):91-100. PubMed ID: 20189297
[TBL] [Abstract][Full Text] [Related]
26. TWEAK and Fn14: new molecular targets for cancer therapy?
Winkles JA; Tran NL; Berens ME
Cancer Lett; 2006 Apr; 235(1):11-7. PubMed ID: 15885893
[TBL] [Abstract][Full Text] [Related]
27. TWEAK induces liver progenitor cell proliferation.
Jakubowski A; Ambrose C; Parr M; Lincecum JM; Wang MZ; Zheng TS; Browning B; Michaelson JS; Baetscher M; Wang B; Bissell DM; Burkly LC
J Clin Invest; 2005 Sep; 115(9):2330-40. PubMed ID: 16110324
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the activities of granulocyte-macrophage colony-stimulating factor and interleukin-8 secretion between two lung epithelial cell lines.
Lee SC; Hsu JY; Fu LS; Chu JJ; Fan SJ; Chi CS
J Microbiol Immunol Infect; 2005 Oct; 38(5):327-31. PubMed ID: 16211140
[TBL] [Abstract][Full Text] [Related]
29. TWEAK promotes the production of Interleukin-17 in rheumatoid arthritis.
Park JS; Park MK; Lee SY; Oh HJ; Lim MA; Cho WT; Kim EK; Ju JH; Park YW; Park SH; Cho ML; Kim HY
Cytokine; 2012 Oct; 60(1):143-9. PubMed ID: 22819243
[TBL] [Abstract][Full Text] [Related]
30. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.
Alexaki VI; Notas G; Pelekanou V; Kampa M; Valkanou M; Theodoropoulos P; Stathopoulos EN; Tsapis A; Castanas E
J Immunol; 2009 Nov; 183(9):5948-56. PubMed ID: 19828625
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-1 binds to specific receptors on human bronchial epithelial cells and upregulates granulocyte/macrophage colony-stimulating factor synthesis and release.
Marini M; Soloperto M; Mezzetti M; Fasoli A; Mattoli S
Am J Respir Cell Mol Biol; 1991 Jun; 4(6):519-24. PubMed ID: 1828952
[TBL] [Abstract][Full Text] [Related]
32. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout mice.
Muñoz-García B; Moreno JA; López-Franco O; Sanz AB; Martín-Ventura JL; Blanco J; Jakubowski A; Burkly LC; Ortiz A; Egido J; Blanco-Colio LM
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2061-8. PubMed ID: 19778942
[TBL] [Abstract][Full Text] [Related]
33. FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK.
Chorianopoulos E; Heger T; Lutz M; Frank D; Bea F; Katus HA; Frey N
Basic Res Cardiol; 2010 Mar; 105(2):301-13. PubMed ID: 19629561
[TBL] [Abstract][Full Text] [Related]
34. TWEAK is expressed at the cell surface of monocytes during multiple sclerosis.
Desplat-Jégo S; Feuillet L; Creidy R; Malikova I; Rance R; Khrestchatisky M; Hahm K; Burkly LC; Pelletier J; Boucraut J
J Leukoc Biol; 2009 Jan; 85(1):132-5. PubMed ID: 18945822
[TBL] [Abstract][Full Text] [Related]
35. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease.
Burkly LC; Michaelson JS; Hahm K; Jakubowski A; Zheng TS
Cytokine; 2007 Oct; 40(1):1-16. PubMed ID: 17981048
[TBL] [Abstract][Full Text] [Related]
36. Functional expression of TWEAK in human hepatocellular carcinoma: possible implication in cell proliferation and tumor angiogenesis.
Kawakita T; Shiraki K; Yamanaka Y; Yamaguchi Y; Saitou Y; Enokimura N; Yamamoto N; Okano H; Sugimoto K; Murata K; Nakano T
Biochem Biophys Res Commun; 2004 Jun; 318(3):726-33. PubMed ID: 15144899
[TBL] [Abstract][Full Text] [Related]
37. Expression of TWEAK and its receptor Fn14 in human subcutaneous adipose tissue. Relationship with other inflammatory cytokines in obesity.
Chacón MR; Richart C; Gómez JM; Megía A; Vilarrasa N; Fernández-Real JM; García-España A; Miranda M; Masdevall C; Ricard W; Caubet E; Soler J; Vendrell J
Cytokine; 2006 Feb; 33(3):129-37. PubMed ID: 16503147
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-13 damages intestinal mucosa via TWEAK and Fn14 in mice-a pathway associated with ulcerative colitis.
Kawashima R; Kawamura YI; Oshio T; Son A; Yamazaki M; Hagiwara T; Okada T; Inagaki-Ohara K; Wu P; Szak S; Kawamura YJ; Konishi F; Miyake O; Yano H; Saito Y; Burkly LC; Dohi T
Gastroenterology; 2011 Dec; 141(6):2119-2129.e8. PubMed ID: 21893119
[TBL] [Abstract][Full Text] [Related]
39. TWEAK is a positive regulator of cardiomyocyte proliferation.
Novoyatleva T; Diehl F; van Amerongen MJ; Patra C; Ferrazzi F; Bellazzi R; Engel FB
Cardiovasc Res; 2010 Mar; 85(4):681-90. PubMed ID: 19887380
[TBL] [Abstract][Full Text] [Related]
40. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.
Tran NL; McDonough WS; Savitch BA; Sawyer TF; Winkles JA; Berens ME
J Biol Chem; 2005 Feb; 280(5):3483-92. PubMed ID: 15611130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
